P1 Competitive economy
1.3. More exports by the Central Baltic companies to new markets
01.09.2015 - 31.12.2018
€1 215 149
ENDED. The existing e-health and life-science clusters see a clear need for a cross-border meta-cluster to solve common challenges of supporting expansion of their innovative companies. The project CB HealthAccess focuses on supporting health technology companies to enter into new distant markets in South Korea, US, India and Uganda with their products.
The project activities include gathering market information (legal setup, rules for health products, financial schemes in health, competition, technological environment, partnerships, etc.), adaption of products, marketing and sales activities, involvement of experts from the target market, business missions, 121 meetings, negotiations and closing of sales. The aim is to establish a lasting relation to the target markets to guarantee smoother access for new innovative health technology companies from the clusters.
The project aims at minimum of three new sales by a company of a participating cluster in each of the four target markets, i.e. 12 new sales in these distant markets. Half of these will be achieved during the project duration and the other half within one year after the end of the CB Health Access project.
SA Tallinna Teaduspark Tehnopol
Partner budget: 261.831 EUR
Amount of ERDF funding: 222.557 EUR ERDF
Tartu Biotehnoloogia Park OÜ
Partner budget: 146.536 EUR
Amount of ERDF funding: 124.555 EUR ERDF
Turku Science Park Oy
Partner budget: 354.370 EUR
Amount of ERDF funding: 265.778 EUR ERDF
Partner budget: 348.741 EUR
Amount of ERDF funding: 261.556 EUR ERDF
Partner budget: 19.026 EUR
Amount of ERDF funding: 16.172 EUR ERDF
Partner budget: 84.645 EUR
Amount of ERDF funding: 63.484 EUR ERDF
The relationships with the selected four distant markets will be open for all four partner clusters and therefore it is possible to continue arranging joint missions, etc. towards these markets and also open new additional markets in the future based on the needs of cluster companies.
CB Health Access main results contribute directly to the program result indicator of cluster co-operations exporting to new markets outside EU/EFTA with focus in innovative products in health (wellness and medicine) sector.
Our consortium covers all health clusters in the Central Baltic region either with direct partnership or with cooperation agreements. Therefore the probability to build a strong meta-cluster in health capable to export to distant markets and continue widening the scope also after this concrete project is considerably high. It is also important to keep in mind that all these clusters offer incubation and export support services and can therefore not only open the access to the distant markets but support the processes, both technology and business, inside individual companies.